We are live on ! Find out more
CA

Crewe Advisors Portfolio holdings

AUM $1.38B
1-Year Est. Return 41.76%
This Fund
S&P 500
This Quarter Est. Return
-2.44%
1 Year Est. Return
+41.76%
3 Year Est. Return
+96.1%
5 Year Est. Return
+98.15%
10 Year Est. Return
AUM
$553M
AUM Growth
+$101M
Cap. Flow
+$126M
Cap. Flow %
22.75%
Top 10 Hldgs %
60.48%
Holding
1,303
New
138
Increased
595
Reduced
38
Closed
14

Sector Composition

Rank Sector Weight
1 Healthcare 21.35%
2 Financials 7.74%
3 Technology 6.78%
4 Consumer Discretionary 4.25%
5 Energy 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTRN icon
476
Materion
MTRN
$4.92B
$19K ﹤0.01%
236
O icon
477
Realty Income
O
$58.9B
$19K ﹤0.01%
324
+78
+32% +$5.38K
PAYX icon
478
Paychex
PAYX
$44.4B
$19K ﹤0.01%
165
+49
+42% +$6.07K
PCAR icon
479
PACCAR
PCAR
$68B
$19K ﹤0.01%
338
+138
+69% +$8.02K
PFG icon
480
Principal Financial Group
PFG
$24B
$19K ﹤0.01%
270
+49
+22% +$3.52K
ROP icon
481
Roper Technologies
ROP
$40.9B
$19K ﹤0.01%
52
+18
+53% +$7.33K
SSNC icon
482
SS&C Technologies
SSNC
$19.5B
$19K ﹤0.01%
390
+42
+12% +$2.42K
TSCO icon
483
Tractor Supply
TSCO
$18.2B
$19K ﹤0.01%
505
+120
+31% +$4.67K
VTR icon
484
Ventas
VTR
$48B
$19K ﹤0.01%
472
+33
+8% +$1.62K
SWCH
485
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$19K ﹤0.01%
560
CCXI
486
DELISTED
ChemoCentryx, Inc.
CCXI
$19K ﹤0.01%
360
ATAI icon
487
AtaiBeckley Inc
ATAI
$2.74B
$18K ﹤0.01%
5,540
CTAS icon
488
Cintas
CTAS
$82.3B
$18K ﹤0.01%
188
+40
+27% +$4.08K
HELP
489
Cybin Inc
HELP
$996M
$18K ﹤0.01%
957
DRI icon
490
Darden Restaurants
DRI
$24.8B
$18K ﹤0.01%
139
+37
+36% +$4.63K
EXC icon
491
Exelon
EXC
$45.8B
$18K ﹤0.01%
492
+200
+68% +$8.84K
GLW icon
492
Corning
GLW
$132B
$18K ﹤0.01%
618
+179
+41% +$6.06K
JBL icon
493
Jabil
JBL
$32.6B
$18K ﹤0.01%
307
PHM icon
494
Pultegroup
PHM
$24.8B
$18K ﹤0.01%
+474
New +$19.9K
TTD icon
495
Trade Desk
TTD
$6.12B
$18K ﹤0.01%
293
+40
+16% +$2.28K
WRK
496
DELISTED
WestRock Company
WRK
$18K ﹤0.01%
595
-200
-25% -$7.9K
AGM icon
497
Federal Agricultural Mortgage
AGM
$2.37B
$17K ﹤0.01%
169
ALNY icon
498
Alnylam Pharmaceuticals
ALNY
$32B
$17K ﹤0.01%
86
+15
+21% +$2.86K
BAH icon
499
Booz Allen Hamilton
BAH
$8.93B
$17K ﹤0.01%
+181
New +$17.2K
BMRN icon
500
BioMarin Pharmaceuticals
BMRN
$12.7B
$17K ﹤0.01%
200
+30
+18% +$2.67K

Similar funds

Crewe Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Crewe Advisors held 1,303 positions worth $553M, up 22% from $453M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Crewe Advisors deployed $126M of net new capital in Q3 2022, opening 138 new positions and adding to 595 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 64 shares worth $26M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 25% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was The Ensign Group, an estimated $827K trimmed.

  • Crewe Advisors's largest Q3 2022 buy was Berkshire Hathaway Class A: 64 shares worth $26M.
  • Crewe Advisors added most to Vanguard Morningstar Small-Cap ETF in Q3 2022, an estimated $19.7M increase.
  • Crewe Advisors's biggest Q3 2022 reduction was The Ensign Group, cutting an estimated $827K.
  • Crewe Advisors fully exited Mantech International Corp in Q3 2022, selling an estimated $17K.
  • Crewe Advisors's ten largest holdings make up 60% of its $553M portfolio in Q3 2022.
  • Crewe Advisors opened 138 new positions and closed 14 in Q3 2022.
  • Crewe Advisors's portfolio value rose 22% quarter-over-quarter to $553M.

Based on Crewe Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.